Mycoplasma Testing Market Is Expected To Grow At A 14.1% CAGR from 2014 to 2025: Grand View Research, Inc.
The global mycoplasma testing market is expected to reach a
value of USD 1.4 billion by 2025, according to a new report by Grand View
Research, Inc. With growing R&D investments in the field of life sciences,
the demand for mycoplasma testing products are anticipated to rise in the near
future. Huge opportunities in the life sciences segment are spurring the market
growth. Hence, a large amount of investment is being made in the biotechnology
and pharmaceutical industries with rising level of healthcare spending across
the globe. This is expected to trigger high growth of mycoplasma testing
market.
Investment in R&D activities
by pharmaceutical and biotechnology companies is increasingly being supported
by the government. Researches involving drug discovery and development, receive
funding from the governmental bodies to a great extent. Moreover, governmental
initiatives in the form of awareness campaigns for chronic diseases such as
cancer are also encouraging research-based activities. Thus, the aforementioned
factors are expected to drive the market growth.
Mycoplasma contamination of cell
culture is a growing concern for most of the research scientists for decades.
Mycoplasma infection arises majorly from laboratory workers as human mycoplasma
contamination occurs at a faster rate. In order to combat further
contamination, mycoplasma tests are being conducted, which is expected to
increase the demand of the related products.
Browse full research
report on Mycoplasma Testing Market: http://www.grandviewresearch.com/industry-analysis/mycoplasma-testing-market
Further Key Findings From the Study Suggest:
- In 2016, kits
& reagents dominated the market and is also expected to show highest
CAGR over the forecast period owing to its wider application in mycoplasma
tests
- Amongst the
technology segment, Polymerase Chain Reaction (PCR) held the largest share
in 2016 owing to the delivery of fast & accurate results associated
with this technology
- Cell line
testing is anticipated to exhibit highest CAGR over the forecast period
due to the increasing risk of cell line contamination
- In 2016,
pharmaceutical and biotechnology companies accounted for the largest
market share due to rising number of research activities in drug discovery
and development
- North America
dominated the market in 2016 owing to rising healthcare spending levels
and government funding for life science-related research
- Some of the
key players are Merck KGaA; Sigma-Aldrich Co.; Thermo Fisher Scientific;
Lonza Group Ltd.; Charles River Laboratories International, Inc.;
PromoCell GmbH; and Bionique Testing Laboratories, Inc.
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-mycoplasma-testing-market
About Grand View Research,
Inc:
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more information: http://www.grandviewresearch.com
Comments
Post a Comment